• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

哮喘患者症状相关中断的改善与短效β-激动剂使用天数减少相关。

Improvement in symptom-related disruptions is associated with fewer days of short-acting beta-agonist use in asthma.

机构信息

ResMed Science Center, San Diego, CA, USA.

ResMed Science Center, Halifax, NS, Canada.

出版信息

NPJ Prim Care Respir Med. 2022 Sep 2;32(1):31. doi: 10.1038/s41533-022-00299-3.

DOI:10.1038/s41533-022-00299-3
PMID:36056022
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9438376/
Abstract

Significant indirect healthcare costs are related to uncontrolled asthma, including productivity loss. Days with short-acting beta-agonist (SABA) use is associated with symptom-related disruptions at work, home, and school. Digital self-management platforms may support fewer days with SABA medication use and may reduce symptom-related disruptions.

摘要

未控制的哮喘会导致大量间接医疗成本，包括生产力损失。使用短效β激动剂（SABA）的天数与工作、家庭和学校的症状相关中断有关。数字自我管理平台可能会减少 SABA 药物使用天数，并减少与症状相关的中断。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c50c/9440091/53f09094318f/41533_2022_299_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c50c/9440091/53f09094318f/41533_2022_299_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c50c/9440091/53f09094318f/41533_2022_299_Fig1_HTML.jpg

相似文献

1
Improvement in symptom-related disruptions is associated with fewer days of short-acting beta-agonist use in asthma.哮喘患者症状相关中断的改善与短效β-激动剂使用天数减少相关。
NPJ Prim Care Respir Med. 2022 Sep 2;32(1):31. doi: 10.1038/s41533-022-00299-3.
2
Retrospective assessment of a collaborative digital asthma program for Medicaid-enrolled children in southwest Detroit: reductions in short-acting beta-agonist (SABA) medication use.对底特律西南部参加医疗补助计划儿童的数字哮喘协作项目的回顾性评估：短效β受体激动剂（SABA）药物使用量的减少
Asthma Res Pract. 2023 May 20;9(1):3. doi: 10.1186/s40733-023-00092-0.
3
Uncontrolled asthma in a commercially insured population from 2002 to 2007: trends, predictors, and costs.2002年至2007年商业保险人群中未控制的哮喘：趋势、预测因素及成本
J Asthma. 2010 Jun;47(5):574-80. doi: 10.3109/02770901003792841.
4
Effect of a mobile health, sensor-driven asthma management platform on asthma control.移动健康、传感器驱动的哮喘管理平台对哮喘控制的影响。
Ann Allergy Asthma Immunol. 2017 Nov;119(5):415-421.e1. doi: 10.1016/j.anai.2017.08.002.
5
Short-acting β-agonist prescription patterns in patients with asthma in Turkey: results from SABINA III.土耳其哮喘患者中短效 β-激动剂处方模式：SABINA III 研究结果。
BMC Pulm Med. 2022 Jun 2;22(1):216. doi: 10.1186/s12890-022-02008-9.
6
Developing a Smartphone Application That Promotes Responsible Short-Acting Beta2-Agonist Use in People with Asthma: A Participatory Design.开发一款促进哮喘患者负责任使用短效β2-激动剂的智能手机应用程序：一项参与式设计。
Int J Environ Res Public Health. 2022 Jul 12;19(14):8496. doi: 10.3390/ijerph19148496.
7
An economic evaluation of budesonide/formoterol for maintenance and reliever treatment in asthma in general practice.布地奈德/福莫特罗在一般实践中用于哮喘的维持和缓解治疗的经济评价。
Adv Ther. 2009 Sep;26(9):872-85. doi: 10.1007/s12325-009-0063-0. Epub 2009 Sep 19.
8
Determination of asthma control using administrative data regarding short-acting beta-agonist inhaler purchase.利用短效β-激动剂吸入器购买的管理数据来确定哮喘控制情况。
J Asthma. 2018 May;55(5):571-577. doi: 10.1080/02770903.2017.1348513. Epub 2017 Aug 16.
9
Assessing asthma control: comparison of electronic-recorded short-acting beta-agonist rescue use and self-reported use utilizing the asthma control test.评估哮喘控制情况：利用哮喘控制测试比较电子记录的短效β-激动剂缓解药物使用情况和自我报告的使用情况。
J Asthma. 2021 Feb;58(2):271-275. doi: 10.1080/02770903.2019.1687715. Epub 2019 Nov 9.
10
Health-care utilization and costs with fluticasone propionate and fluticasone propionate/salmeterol in asthma patients at risk for exacerbations.丙酸氟替卡松和丙酸氟替卡松/沙美特罗用于有加重风险的哮喘患者时的医疗保健利用情况及成本
Allergy Asthma Proc. 2014 Jan-Feb;35(1):54-62. doi: 10.2500/aap.2014.35.3720.

引用本文的文献

1
Clinically-enhanced digital health program for respiratory care associated with better medication use and retention.用于呼吸护理的临床增强型数字健康计划，与更好的药物使用和留存率相关。
NPJ Prim Care Respir Med. 2024 Dec 28;34(1):46. doi: 10.1038/s41533-024-00404-8.
2
Effects of constant-load exercise and high-intensity interval training on reliever medication consumption and peak expiratory flow in individuals with asthma: a randomised controlled trial.持续负荷运动和高强度间歇训练对哮喘患者缓解药物消耗及呼气峰值流速的影响：一项随机对照试验
ERJ Open Res. 2024 Mar 11;10(2). doi: 10.1183/23120541.00899-2023. eCollection 2024 Mar.

本文引用的文献

1
Effect of electronic adherence monitoring on adherence and outcomes in chronic conditions: A systematic review and meta-analysis.电子依从性监测对慢性病患者依从性和结局的影响：系统评价和荟萃分析。
PLoS One. 2022 Mar 21;17(3):e0265715. doi: 10.1371/journal.pone.0265715. eCollection 2022.
2
Work absence in patients with asthma and/or COPD: a population-based study.哮喘和/或 COPD 患者的缺勤情况：一项基于人群的研究。
NPJ Prim Care Respir Med. 2021 Feb 16;31(1):9. doi: 10.1038/s41533-021-00217-z.
3
The Impact of Patient Self-Monitoring Via Electronic Medication Monitor and Mobile App Plus Remote Clinician Feedback on Adherence to Inhaled Corticosteroids: A Randomized Controlled Trial.
患者通过电子用药监测仪和移动应用程序进行自我监测并接收远程临床医生反馈对吸入性皮质类固醇依从性的影响：一项随机对照试验。
J Allergy Clin Immunol Pract. 2021 Apr;9(4):1586-1594. doi: 10.1016/j.jaip.2020.10.064. Epub 2020 Nov 16.
4
Medical Costs and Productivity Loss Due to Mild, Moderate, and Severe Asthma in the United States.美国轻度、中度和重度哮喘导致的医疗成本及生产力损失
J Asthma Allergy. 2020 Oct 29;13:545-555. doi: 10.2147/JAA.S272681. eCollection 2020.
5
The Adoption and Implementation of Digital Health Care in the Post-COVID-19 Era.后新冠疫情时代数字医疗保健的采用与实施
J Allergy Clin Immunol Pract. 2020 Sep;8(8):2484-2486. doi: 10.1016/j.jaip.2020.06.006. Epub 2020 Jun 22.
6
Telehealth delivery of adherence and medication management system improves outcomes in inner-city children with asthma.远程医疗提供的依从性和药物管理系统改善了城市内哮喘儿童的预后。
Pediatr Pulmonol. 2020 Apr;55(4):858-865. doi: 10.1002/ppul.24623. Epub 2020 Jan 6.
7
Assessing asthma control: comparison of electronic-recorded short-acting beta-agonist rescue use and self-reported use utilizing the asthma control test.评估哮喘控制情况：利用哮喘控制测试比较电子记录的短效β-激动剂缓解药物使用情况和自我报告的使用情况。
J Asthma. 2021 Feb;58(2):271-275. doi: 10.1080/02770903.2019.1687715. Epub 2019 Nov 9.
8
The Projected Economic and Health Burden of Uncontrolled Asthma in the United States.美国未控制哮喘的经济和健康负担预测。
Am J Respir Crit Care Med. 2019 Nov 1;200(9):1102-1112. doi: 10.1164/rccm.201901-0016OC.
9
The Economic Burden of Asthma in the United States, 2008-2013.美国 2008-2013 年哮喘经济负担
Ann Am Thorac Soc. 2018 Mar;15(3):348-356. doi: 10.1513/AnnalsATS.201703-259OC.
10
Development of the asthma control test: a survey for assessing asthma control.哮喘控制测试的开发：一项评估哮喘控制情况的调查
J Allergy Clin Immunol. 2004 Jan;113(1):59-65. doi: 10.1016/j.jaci.2003.09.008.